Email:
|
ivana.jochmanova@upjs.sk | |
Homepage:
|
https://www.upjs.sk/LF/zamestnanec/ivana.jochmanova | |
Faculty:
|
LF UPJŠ
-
Pavol Jozef Šafárik University in Košice Faculty of Medicine
|
|
Department:
|
1. IK
-
1st Department of Internal Medicine
|
|
Office:
|
MH5O08E | |
Phone:
|
+421 55 234 3496 | |
Faculty:
|
LF UPJŠ
-
Pavol Jozef Šafárik University in Košice Faculty of Medicine
|
|
Department:
|
KNM
-
Department of Nuclear Medicine
|
|
Office:
|
||
Phone:
|
||
ORCID ID:
|
0000-0003-2346-461X |
Profile courses
|
Internal Medicine 1, 2, 3, 4, 5, 6 - General Medicine, I.+II. degree
|
Internal Medicine 1, 2, 3, 4 - Dental Medicine, I.+II. degree
|
Propedeutics in Internal Medicine - Dental Medicine, I.+II. degree
|
Propedeutics in Internal Medicine - General Medicine, I.+II. degree
|
Internal Medicine Clerkship - General Medicine, I.+II. degree
|
Selected publications
|
Hadrava Vanova K, Pang Y, Krobova L, Kraus M, Nahacka Z, Boukalova S, Pack SD, Zobalova R, Zhu J, Huynh TT, Jochmanova I, Uher O, Hubackova S, Dvorakova S, Garrett TJ, Ghayee HK, Wu X, Schuster B, Knapp PE, Frysak Z, Hartmann I, Nilubol N, Cerny J, Taieb D, Rohlena J, Neuzil J, Yang C, Pacak K. Germline SUCLG2 Variants in Patients With Pheochromocytoma and Paraganglioma. In Journal of the National Cancer Institute. 2022; 114(1):130-138. DOI10.1093/jnci/djab158. IF 13.893 |
Jochmanova I, Pacak K. Pheochromocytoma: The First Metabolic Endocrine Cancer. Clin Cancer Res. 2016;22(20):5001-5011. IF 10.107. |
Jochmanova I, Abcede AMT, Guerrero RJS, Malong CLP, Wesley R, Huynh T, Gonzales MK, Wolf KI, Jha A, Knue M, Prodanov T, Nilubol N, Mercado-Asis LB, Stratakis CA, Pacak K. Clinical characteristics and outcomes of SDHB-related pheochromocytoma and paraganglioma in children and adolescents. In J Cancer Res Clin Oncol. 2020 Apr;146(4):1051-1063. IF 4.553 |
Caisova V, Li L, Gupta G, Jochmanova I, Jha A, Uher O, Huynh T-T, Miettinen M, Pang Y, Abunimer L, Niu G, Chen X , Ghayee HK, Taïeb D, Zhuang Z, Zenka J, Pacak K. The Significant Reduction or Complete Eradication of Subcutaneous and Metastatic Lesions in a Pheochromocytoma Mouse Model after Immunotherapy Using Mannan-BAM, TLR Ligands, and Anti-CD40. Cancers. 2019;11:654. doi:10.3390/cancers11050654. IF 6.639 |
Jochmanova I, Wolf KI, King KS, Nambuba J, Wesley R, Martucci V, Raygada M, Adams KT, Prodanov T, Fojo AT, Lazurova I, Pacak K. SDHB-related Pheochromocytoma and Paraganglioma Penetrance and Genotype-Phenotype Correlations. J Cancer Res Clin Oncol. 2017;143(8):1421-1435. doi: 10.1007/s00432-017-2397-3. IF 4.553 |
Selected projects
|
KEGA 023UPJŠ-4/2017 |
VEGA 1/0364/17 |
International mobilities and visits
|
National Instutes of Health, Bethesda, MD, USA, 2014-2017, visiting research fellow
|
Organisational activities
|
Member - Slovak Endocrine Society
|
Member - European society of endocrinology
|
Member - Endocrine Society
|
Member - European Network for the Study of Adrenal Tumours (ENS@T)
|
Member - COST Harmonis@tion
|